Georgia Capital Shareholder and Market Opportunity Overview
Private large
portfolio companies
EXTERNALLY VALUED
GHG'S TRACK RECORD OF DELIVERING
STRONG RESULTS
REVENUE, GROSS (GEL MILLION)
CAGR 31.7%
920.3
975.4
849.9
747.8
426.4
246.0
EBITDA1 (GEL MILLION)
+6.3%
CAGR 20.0%
250.1 265.8
108.1
145.2
132.3
139.4
78.0
56.1
GEORGIA
CAPITAL
OPERATING CASH FLOW1 (GEL MILLION)
EBITDA to cash conversion ratio²:
81%
54%
54% 75% 84%
112%
119% 5%
CAGR 28.1%
-95.1%
+8.1%
156.5
121.2
99.6
34.3
37.0
45.4
58.2
42.4
40.8
2.0
2015 2016 2017 2018 2019 2020 1Q20 1Q21
2015
2016
2017
2018
2019
2020 1Q20 1Q21
2015
2016
2017 2018 2019
2020 1Q20 1Q21
CAPEX (GEL MILLION)
ROIC (%)
Start of the Capex
Peak Capex stage
programme
Phase out from
Capex
programme
Pursuing value creation and delivering strong operational
performance
13.9%
111.0
15%
12.7% 13.1%
11.8%
9.4
89.3
10.8% 11.0%
71.2
9.6
63.7
9.6%
10%
7.2
11.1
39.7
101.6
30.3
79.7
64.0
11.9
8.3
8.8
52.6
10.0
3.0
27.8
2.7
20.3
5%
5.6
5.8
2015
2016
2017
2018
2019
2020
1Q20
1Q21
■Development Capex
■Maintenance Capex
Georgia Capital PLC | General note: 2019 and 2020 numbers are adjusted to exclude HTMC hospital, sold in August 2020. 1. Excluding IFRS16 impact
0%
2016
2017
2018
2019
2020
1Q20
1Q21
44View entire presentation